Opendata, web and dolomites

LPPDS

A portable peritoneal dialysis system for home use that monitors for infection

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 LPPDS project word cloud

Explore the words cloud of the LPPDS project. It provides you a very rough idea of what is the project "LPPDS" about.

end    kidney    filtering    peristaltic    esrd    carry    obesity    share    times    chronic    ux    requiring    truly    speeds    sterile    prevalence    seeing    health    decreasing    plans    consists    eskd    caused    population    schedules    external    saving    revolutionises    poorer    session    hd    stage    difficult    core    hospitals    time    latter    haemodialysis    53    hypertension    efficacy    longer    doctors    doctor    protocol    centres    travelling    patent    lightweight    globally    treatment    offerings    peritoneal    travel    compliance    choosing    exchange    occurs    human    either    public    smart    rate    function    pd    fifth    last    adding    monitoring    diabetes    market    lppds    holds    issue    ckd    liberdi    minutes    economic    west    aging    sufficiently    pump    socio    transplant    blood    takes    day    kidneys    correct    disposable    week    decline    dialysis    catheters    errors    ease    automation    pending    renal    designed    inhibit    adherence    disease    reduce    connectors    calculate    complexity    device    recognised    flow    home    hours    portable    patients    waste    epidemics    fluid    patient   

Project "LPPDS" data sheet

The following table provides information about the project.

Coordinator
LIBERDI LTD 

Organization address
address: 17 T'CHELET STREET
city: MISGAV
postcode: 2017400
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website http://www.liberdi.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-08-01   to  2018-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LIBERDI LTD IL (MISGAV) coordinator 50˙000.00

Map

 Project objective

End Stage Kidney Disease (ESKD) or End Stage Renal Disease (ESRD), the fifth and last stage of Chronic Kidney Disease (CKD), is recognised as a major public health problem. It occurs where kidneys are no longer capable of sufficiently filtering waste products from the blood. With kidney function at less than 10 %, a kidney transplant or an external means of filtering is needed. The latter consists of either Haemodialysis (HD) or Peritoneal Dialysis (PD). Globally, we are seeing an increasing prevalence in ESRD. This is caused by an aging population in the west, socio-economic factors, increasing hypertension, and growing diabetes and obesity epidemics.

The technical complexity of market offerings can inhibit many patients from choosing PD. HD takes an average of 4 hours per treatment session and occurs 3 times a week while PD occurs 4 times a day with each exchange requiring 40 minutes on average. Most dialysis occurs in specific dialysis centres and hospitals, adding further time for travel. Non-compliance with treatment schedules are a particular issue with PD. This makes it difficult for doctors to calculate correct treatment plans as patients may not share this information with their doctor. Non-compliance can be as high as 53%, decreasing efficacy of the treatment leading to poorer health overall and speeds up rate of decline.

liberDi revolutionises traditional Peritoneal Dialysis with LPPDS, a smart, real-time, patient-monitoring, truly portable device. It’s lightweight, easy to set up and allows patients carry out their dialysis at home, at work or while travelling. LPPDS has UX at the very core of its design to ensure ease of use: patent pending smart automation, catheters and sterile connectors. The system consists of a patent-pending disposable that holds a smart peristaltic pump designed to improve adherence to protocol, and reduce human errors, while saving time via fluid flow rate and management.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LPPDS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LPPDS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More  

COPI (2020)

Carbon Offset Plug-in

Read More